Mesothelioma Cancer Centers
The David H. Koch Integrative Center for Cancer Research at the Massachusetts Institute of Technology (MIT), formerly the MIT Center for Cancer Research (CCR), was founded in 1974 and is a National Cancer Institute-designated Basic Cancer Research Center, one of eight such non-clinical facilities in the U.S. with this designation. It employs about two dozen biologists and engineers, a staff that is supported by numerous post-doctoral fellows and associates and other personnel at MIT.
A leader in the field of cancer research, Koch/CCR has had a hand in many notable cancer discoveries including the sequencing of the human genome and the isolation of the first human cancer genes. The former and current faculty at Koch includes five individuals who have earned the Nobel Prize in their field and a host of other professionals who have received numerous national and international prizes in the science field.
The research center itself does not see patients nor is it affiliated with any hospitals or cancer centers. However, the researchers here do collaborate with clinicians at other institutions. Also, clinical trials are not conducted at this facility. Rather, the investigators at Koch/CCR focus solely on the study on various kinds of cancer like asbestos cancer, striving to better understand its causes, how it progresses, and how it can best be treated. Any interaction with patient cases is done on an anonymous basis. However, because the research here focuses on the "basics", such as why normal cells are converted into cancer cells, the discoveries made at Koch can benefit patients with all types of cancer like mesothelioma.
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette
David H. Koch Center of Comprehensive Cancer Research at MIT